1231892-74-2 Usage
General Description
The chemical "7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinolin-1(2H)-one" is a complex organic compound containing boron and nitrogen. It is a nitrogen-containing heterocycle with a boron-containing side group. 7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinolin-1(2H)-one has potential applications in pharmaceutical and material science due to its unique chemical structure and properties. Further research on this chemical may lead to the development of new drugs or materials with specific properties. However, it is important to note that this compound may have specific handling and safety requirements due to its chemical properties.
Check Digit Verification of cas no
The CAS Registry Mumber 1231892-74-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,3,1,8,9 and 2 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1231892-74:
(9*1)+(8*2)+(7*3)+(6*1)+(5*8)+(4*9)+(3*2)+(2*7)+(1*4)=152
152 % 10 = 2
So 1231892-74-2 is a valid CAS Registry Number.
1231892-74-2Relevant articles and documents
INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN
-
, (2020/07/14)
Compounds and compositions for modulating fibroblast activation protein (FAP) are described. The compounds and compositions may find use as therapeutic agents for the treatment of diseases, including hyperproliferative diseases.
BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS
-
, (2017/08/01)
The invention provides a compound of formula (0): or a pharmaceutically acceptable salt, N-oxide or tautomer thereof. The compounds are inhibitors of ERK 1/2 kinases and will be useful in the treatment of ERKl/2-mediated conditions. The compounds are therefore useful in therapy, in particular in the treatment of cancer.
BENZOXAZINONE DERIVATIVES AND ANALOGUES THEREOF AS MODULATORS OF TNF ACTIVITY
-
, (2016/12/26)
A series of substituted 3,4-dihydro-2H-.1,4-benzoxazin-3-one derivatives, and analogues thereof, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune